Investor Presentaiton

Executive Summary · • Clinically validated technology: richer diagnostic value, safer, lower cost. Significant global market with attractive growth opportunities in the core U.S. market. Top tier relationships: clinical and commercial Massively scalable SaaS business model. Strong pipeline protected by a strong (and growing) IP portfolio. Highly experienced Board of Directors and senior management. 4DMedical Limited | Investor Presentation | November 2022 4DMedical™ 35

View entire presentation